Value Proposition:
• This technology has an application to address a major patient need.
• The ability to reliably diagnose malaria infections.
• The monoclonal antibodies specific to aldolase.
Technical Details:
Malaria is severe disease and caused by a parasite called Plasmodium. According to the World Health Organization, there were 247 million malaria cases and nearly a million deaths in 2006. Key intervention to control malaria is prompt and effective treatment with first step of good and reliable diagnostic testing. Hybridoma Clone PVALD 434-3 4A4.2E12 or PVALD 434-3 4A4.6B10 producing the monoclonal antibodies that are specific to an abundant malaria protein called aldolase, which recognizes all species of Plasmodium.
Looking for Partners:
The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.
